WuXi AppTec Co., Ltd. (WUXIF)
USD 7.12
(0.0%)
USD 7.12
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 40.34 Billion CNY | 2.51% |
| 2022 | 39.35 Billion CNY | 71.84% |
| 2021 | 22.9 Billion CNY | 38.5% |
| 2020 | 16.53 Billion CNY | 28.46% |
| 2019 | 12.87 Billion CNY | 33.89% |
| 2018 | 9.61 Billion CNY | 23.8% |
| 2017 | 7.76 Billion CNY | 26.96% |
| 2016 | 6.11 Billion CNY | 25.24% |
| 2015 | 4.88 Billion CNY | 17.96% |
| 2014 | 4.13 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 7.98 Billion CNY | -26.09% |
| 2024 Q3 | 10.46 Billion CNY | 12.98% |
| 2024 Q2 | 9.25 Billion CNY | 16.0% |
| 2023 Q2 | 9.9 Billion CNY | 10.53% |
| 2023 FY | 40.34 Billion CNY | 2.51% |
| 2023 Q1 | 8.96 Billion CNY | -18.22% |
| 2023 Q3 | 10.67 Billion CNY | 7.7% |
| 2023 Q4 | 10.79 Billion CNY | 1.21% |
| 2022 Q3 | 10.63 Billion CNY | 14.61% |
| 2022 Q1 | 8.47 Billion CNY | 32.81% |
| 2022 FY | 39.35 Billion CNY | 71.84% |
| 2022 Q2 | 9.28 Billion CNY | 9.53% |
| 2022 Q4 | 10.96 Billion CNY | 3.03% |
| 2021 FY | 22.9 Billion CNY | 38.5% |
| 2021 Q4 | 6.38 Billion CNY | 6.62% |
| 2021 Q2 | 5.58 Billion CNY | 12.84% |
| 2021 Q1 | 4.95 Billion CNY | 4.87% |
| 2021 Q3 | 5.98 Billion CNY | 7.14% |
| 2020 Q2 | 4.04 Billion CNY | 26.87% |
| 2020 Q1 | 3.18 Billion CNY | -11.3% |
| 2020 Q3 | 4.58 Billion CNY | 13.34% |
| 2020 FY | 16.53 Billion CNY | 28.46% |
| 2020 Q4 | 4.72 Billion CNY | 2.99% |
| 2019 Q4 | 3.59 Billion CNY | 6.19% |
| 2019 Q2 | 3.12 Billion CNY | 12.83% |
| 2019 Q1 | 2.76 Billion CNY | 2.86% |
| 2019 FY | 12.87 Billion CNY | 33.89% |
| 2019 Q3 | 3.38 Billion CNY | 8.3% |
| 2018 Q1 | 2.14 Billion CNY | 2.61% |
| 2018 FY | 9.61 Billion CNY | 23.8% |
| 2018 Q2 | 2.26 Billion CNY | 5.87% |
| 2018 Q4 | 2.69 Billion CNY | 7.19% |
| 2018 Q3 | 2.51 Billion CNY | 10.78% |
| 2017 FY | 7.76 Billion CNY | 26.96% |
| 2017 Q4 | 2.08 Billion CNY | 3.72% |
| 2017 Q3 | 2.01 Billion CNY | 6.08% |
| 2017 Q1 | 1.76 Billion CNY | 0.0% |
| 2017 Q2 | 1.89 Billion CNY | 7.3% |
| 2016 FY | 6.11 Billion CNY | 25.24% |
| 2015 FY | 4.88 Billion CNY | 17.96% |
| 2014 FY | 4.13 Billion CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -4418389.253% |
| Arrayit Corporation | 4.37 Million USD | -921491.092% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | -155908.999% |
| Bioqual, Inc. | 58.59 Million USD | -68751.602% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | -263634.355% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | -446.324% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -633569.695% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -3836072.546% |
| Interpace Biosciences, Inc. | 40.21 Million USD | -100215.33% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -9014625.592% |
| InVitro International | 792.62 Thousand USD | -5089400.608% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | -362318.533% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | -558310.09% |
| NovelStem International Corp. | 12 Thousand USD | -336173290.633% |
| Optigenex Inc. | 465.97 Thousand USD | -8657282.852% |
| PharmChem, Inc. | 6.01 Million USD | -670859.796% |
| Proteome Sciences plc | 6.4 Million USD | -630161.687% |
| Response Genetics, Inc | 18.04 Million USD | -223518.663% |
| Rennova Health, Inc. | 13.03 Million USD | -309352.858% |
| RushNet, Inc. | 1.78 Million USD | -2256248.685% |
| ScreenPro Security Inc. | 1.91 Million USD | -2107456.745% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -1062877.576% |
| Todos Medical Ltd. | 7.69 Million USD | -524147.003% |